Article
Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation
by
M. Teresa de la Morena;
David Leonard;
Troy R. Torgerson;
Otavio Cabral-Marques;
Mary Slatter;
Asghar Aghamohammadi;
Sharat Chandra;
Luis Murguia-Favela;
Francisco A. Bonilla;
Maria Kanariou;
Rongras Damrongwatanasuk;
Caroline Y. Kuo;
Christopher C. Dvorak;
Isabelle Meyts;
Karin Chen;
Lisa Kobrynski;
Neena Kapoor;
Darko Richter;
Daniela DiGiovanni;
Fatima Dhalla;
Evangelia Farmaki;
Carsten Speckmann;
Teresa Espanol;
Anna Scherbina;
Imelda Celine Hanson;
Jiri Litzman;
John M. Routes ;
Melanie Wong;
Ramsay Fuleihan;
Suranjith L. Seneviratne;
Trudy N. Small;
Ales Janda ;
Liliana Bezrodnik;
Reinhard Seger;
Andrea Gomez Raccio;
J. David M. Edgar;
Janet Chou;
Jordan K. Abbott;
Joris van Montfrans;
Luis Ignacio Gonzalez-Granado;
Nancy Bunin;
Necil Kutukculer;
Paul Gray;
Gisela Seminario;
Srdjan Pasic;
Victor Aquino;
Christian Wysocki;
Hassan Abolhassani;
Morna Dorsey;
Charlotte Cunningham-Rundles;
Alan P. Knutsen;
John Sleasman;
Beatriz Tavares Costa Carvalho;
Antonio Condino-Neto;
Eyal Grunebaum;
Helen Chapel;
Hans D. Ochs;
Alexandra Filipovich;
Mort Cowan ;
Andrew Gennery;
Andrew Cant ;
Luigi D. Notarangelo;
Chaim Roifman
2017